Growth can be attributed to increasing ageing population; increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests. For instance, According to the WHO, the population aged 60 years and over across the globe is expected to double from about 11% in 2000 to 22% in 2050. The number of people over 60 years of age will increase from 605 million to 2 Billion over the same period. Similarly, according to GLOBOCAN, globally, the incidence of cancer was 15.2 Million in 2015 and is expected to reach 19 Million by 2025.
Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.
The anatomic pathology market was valued at USD 16.2 Billion in 2016 and poised to grow at a CAGR of 6.1% between 2016 and 2021, to reach USD 21.9 Billion in 2021.
Value Addition for the Buyer:
This report aims to provide insights into the global market. It provides valuable information on anatomic pathology product & service and application. Details on regional Anatomical pathology markets for these segments are also presented in this report. In addition, leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.
To know about the assumptions considered for the study, download the pdf brochure
Geographically, the anatomic pathology market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The growing prevalence of chronic diseases, rapidly increasing aging population, rising acceptance of personalized medicine, growing academic and government investments in diagnostic research, and the presence of a large number of major market players in this region are further driving the growth of this Anatomical pathology market.
Key players operating in the market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
